Beijing Honglin Pharmaceutical Ltd. Amlodipine Besylate Tablet passed the Generic Drug Consistency Evaluation!!

Recently, following the JUPOPINE^® (Nefedipine Controlled-Release Tablets) & RoToFier^® (Glipizide Extended Release Tablets), respectively, the National Medical Products Administration (NMPA) issued the certificate of Generic Drug Consistency Evaluation for Amlodipine Besylate Tablets to Beijing Honglin Pharmaceutical in response to the "Drug Application of Supplementary Amendments". This also makes Amlodipine the 3rd product of Honglin which passed the Generic Drug Consistency Evaluation.

Amlodipine Besylate Tablets follows the formula of Norvasc from Pfizer pharmaceuticals in USA, major targets are all types of hypertension and Coronary artery diseases. It's one of the highly recommended anti-hypertension drugs proposed by Official references. It is also able to be taken together with other kinds of medication. "1 pill per day" makes patients have better compliance.